HUMA - Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting
Story updates
12:01:31 PM UTC
SquawkNews
HUMA Humacyte announces FDA Acceptance of ind for first-in-human clinical study of ctev for coronary artery bypass grafting Humacyte - to initiate phase 2a ctev study in cabg this quarter
12:23:32 PM UTC
SquawkNews
Humacyte announced that...
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.